Table 3.

Summary of Patient Response Following Kisspeptin-54 Triggering

Kisspeptin-54 Dose	3.2	6.4	9.6	12.8	Total
N	5	20	15	20	60
≥ 1 mature oocyte retrieved	4	20	14	19	57
≥ 1 2PN zygote formeda	4	18	13	19	54
Segmentationb	0	1	0	2	3
No. of patients with embryo transfer	4	17	13	17	51
No. of patients with day 5 transferc	4	15	11	17	47
High-quality embryo transferd	3	13	9	13	37
Biochemical pregnancy at 11 d	2	11	11	8	32
Clinical pregnancy at 6 wk	1	10	10	6	27
Miscarriage/still birth	0	1	2	1	4
Live birth	1	9	8	5	23

Data are presented as the number of patients completing each criterion.

^a2PN is two pronuclear zygote assessed on day following oocyte retrieval.

^bSegmentation refers to cryopreservation of all embryos and embryo transfer in a subsequent frozen cycle due to high risk of OHSS.

^cEmbryo transfer on day 5.

^dTransfer of at least one high-quality embryo. High-quality embryos were blastocyst embryos graded on day 5 as being ≥ 3A or B in quality (30).